252 related articles for article (PubMed ID: 27575542)
21. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
[TBL] [Abstract][Full Text] [Related]
22. Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients.
de Wall C; Sabine D; Gregor W; Mark G; Axel H; Thomas F; Tobias W; Jens G
Respir Med; 2014 Feb; 108(2):405-12. PubMed ID: 24445061
[TBL] [Abstract][Full Text] [Related]
23. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
[TBL] [Abstract][Full Text] [Related]
24. Relationship between FEV
Kemp R; Pustulka I; Boerner G; Smela B; Hofstetter E; Sabeva Y; François C
Respir Med; 2021 Nov; 188():106608. PubMed ID: 34517199
[TBL] [Abstract][Full Text] [Related]
25. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
Norman BC; Jacobsohn DA; Williams KM; Au BK; Au MA; Lee SJ; Moravec CK; Chien JW
Bone Marrow Transplant; 2011 Oct; 46(10):1369-73. PubMed ID: 21132024
[TBL] [Abstract][Full Text] [Related]
26. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.
Verleden GM; Dupont LJ
Transplantation; 2004 May; 77(9):1465-7. PubMed ID: 15167610
[TBL] [Abstract][Full Text] [Related]
27. [Azithromycin as a novel treatment for bronchiolitis obliterans syndrome].
Peled N; Shitrit D; Bendayan D; Kramer MR
Harefuah; 2007 Mar; 146(3):219-22, 245. PubMed ID: 17460931
[TBL] [Abstract][Full Text] [Related]
28. Nintedanib in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation.
Tang W; Yu T; Dong T; Liu T; Ji J
Chest; 2020 Sep; 158(3):e89-e91. PubMed ID: 32892892
[TBL] [Abstract][Full Text] [Related]
29. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
[TBL] [Abstract][Full Text] [Related]
30. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation.
Barisione G; Bacigalupo A; Crimi E; Brusasco V
Chest; 2011 Mar; 139(3):633-639. PubMed ID: 20724742
[TBL] [Abstract][Full Text] [Related]
31. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Verleden GM; Dupont LJ; Van Raemdonck DE
Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
[TBL] [Abstract][Full Text] [Related]
32. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
[TBL] [Abstract][Full Text] [Related]
33. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.
Yates B; Murphy DM; Forrest IA; Ward C; Rutherford RM; Fisher AJ; Lordan JL; Dark JH; Corris PA
Am J Respir Crit Care Med; 2005 Sep; 172(6):772-5. PubMed ID: 15976371
[TBL] [Abstract][Full Text] [Related]
34. [Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation].
Cao XP; Han DM; Wang ZD; Zheng XL; Ding L; Yan HM; Xue M; Zhu L; Liu J; Guo ZK; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):173-7. PubMed ID: 26913416
[TBL] [Abstract][Full Text] [Related]
35. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
[TBL] [Abstract][Full Text] [Related]
36. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
Cheng GS; Bondeelle L; Gooley T; He Q; Jamani K; Krakow EF; Flowers MED; de Latour RP; Michonneau D; Socié G; Chien JW; Chevret S; Bergeron A
Biol Blood Marrow Transplant; 2020 Feb; 26(2):392-400. PubMed ID: 31682980
[TBL] [Abstract][Full Text] [Related]
37. Detection of Bronchiolitis Obliterans Syndrome Using Nitrogen Multiple Breath Washout in Children Posthemopoietic Stem Cell Transplant.
Westrupp N; Berry CD; Cole T; Shanthikumar S; Welsh L
Transplant Cell Ther; 2024 May; 30(5):524.e1-524.e9. PubMed ID: 38360272
[TBL] [Abstract][Full Text] [Related]
38. Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.
Bergeron A; Chevret S; Chagnon K; Godet C; Bergot E; Peffault de Latour R; Dominique S; de Revel T; Juvin K; Maillard N; Reman O; Contentin N; Robin M; Buzyn A; Socié G; Tazi A
Am J Respir Crit Care Med; 2015 Jun; 191(11):1242-9. PubMed ID: 25835160
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study.
Chen S; Zhao K; Lin R; Wang S; Fan Z; Huang F; Chen X; Nie D; Du X; Guo Z; Lin D; Xuan L; Xu N; Sun J; Peng Xiang A; Liu Q
EBioMedicine; 2019 Nov; 49():213-222. PubMed ID: 31668569
[TBL] [Abstract][Full Text] [Related]
40. Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
Brownback KR; Thomas LA; McGuirk JP; Ganguly S; Streiler C; Abhyankar S
Lung; 2017 Dec; 195(6):781-788. PubMed ID: 28894914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]